CNMD (STOCKS)
CONMED Corporation
$49.820000
+0.340000 (+0.69%)
Prev close: $49.480000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Patrick Joseph Beyer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,491.87M
- Employees
- 3,900
- P/E (TTM)
- 26.76
- P/B (TTM)
- 1.42
- Dividend Yield
- 40.42%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.37B |
| Benefits Costs and Expenses | $1.29B |
| Cost Of Revenue | $606.35M |
| Costs And Expenses | $1.29B |
| Gross Profit | $765.31M |
| Operating Expenses | $654.99M |
| Selling, General, and Administrative Expenses | $594.35M |
| Research and Development | $60.63M |
| Operating Income/Loss | $110.32M |
| Income/Loss From Continuing Operations After Tax | $56.50M |
| Income/Loss From Continuing Operations Before Tax | $83.23M |
| Income Tax Expense/Benefit | $26.73M |
| Income Tax Expense/Benefit, Deferred | $8.18M |
| Interest Expense, Operating | $29.92M |
| Net Income/Loss | $56.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $56.50M |
| Net Income/Loss Available To Common Stockholders, Basic | $56.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.85 |
| Diluted Earnings Per Share | $1.85 |
| Basic Average Shares | 61,279,000 |
| Diluted Average Shares | 61,411,000 |
| Assets | $2.30B |
| Current Assets | $675.67M |
| Inventory | $360.18M |
| Other Current Assets | $315.49M |
| Noncurrent Assets | $1.62B |
| Fixed Assets | $110.14M |
| Intangible Assets | $564.42M |
| Other Non-current Assets | $950.08M |
| Liabilities | $1.26B |
| Current Liabilities | $455.40M |
| Accounts Payable | $101.02M |
| Wages | $70.42M |
| Other Current Liabilities | $283.97M |
| Noncurrent Liabilities | $803.52M |
| Equity | $1.04B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.04B |
| Liabilities And Equity | $2.30B |
| Net Cash Flow From Operating Activities | $150.59M |
| Net Cash Flow From Operating Activities, Continuing | $150.59M |
| Net Cash Flow From Investing Activities | $3.38M |
| Net Cash Flow From Investing Activities, Continuing | $3.38M |
| Net Cash Flow From Financing Activities | -$149.68M |
| Net Cash Flow From Financing Activities, Continuing | -$149.68M |
| Exchange Gains/Losses | -$889.00K |
| Net Cash Flow | $3.39M |
| Net Cash Flow, Continuing | $4.28M |
| Comprehensive Income/Loss | $66.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $66.10M |
| Other Comprehensive Income/Loss | $19.05M |